Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39308777.
- Also identified by DOI 10.1016/j.lanepe.2024.101073 and PMC identifier 11415942.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1016/j.lanepe.2023.100829.].